Femoropopliteal Artery Disease Clinical Trial
- Prospective, single-arm, multi-center registry study
- A total of 150 subjects with femoropopliteal artery disease who meet all inclusion and
exclusion criteria will be included.
- Patients will be followed clinically for 12 months after the procedure.
- Duplex ultrasound, CT or catheter-based angiography follow-up according to participating
hospital's protocol will be performed at 12 months.
- Presence of stent fracture will be evaluated by plain radiography or fluoroscopy at 12
months.
- Quality of life by standardized questionnaires (at baseline & at 1 & 12 months)
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02145065 -
First-in-man Evaluation of a Novel, Microcrystalline Paclitaxel Coated Balloon for Treatment of Femoropopliteal Artery Disease (PAX-r)
|
N/A | |
| Recruiting |
NCT05307263 -
Combination Therapy of Atherectomy Plus Drug-coated Balloon Versus Drug-coated Balloon for Complex Femoropopliteal Artery Disease
|
N/A | |
| Completed |
NCT03517904 -
Comparison of Intravascular Ultrasound-Guided vs. Angiography-guided Angioplasty and Dual-antiplatelet v. Triple-antiplatelet Therapy for Outcomes of Drug-coated Balloon in the Treatment of Femoropopliteal Artery Disease (IVUS-DCB)
|
N/A | |
| Recruiting |
NCT02701881 -
Comparison of the PrimAry Long Versus Short Coverage With Drug-Eluting Stents for Long FemoRopopliteal Artery DiseasE (PARADE II): Investigator-initiated Clinical Study
|
Phase 4 |